Asitri Dashboard

Search Clinical Trials

The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.

Saved Searches

Choose Search
Basic Search
Targeted Search

Clinical Trials Search Results

Search History:
Count: 285
Selected: 0
NCT IDTitle
NCT05918640Lurbinectedin in FET-Fused Tumors
NCT05009992Combination Therapy for the Treatment of Diffuse Midline Gliomas
NCT06261502Effect of CANnabidiol on Anxiety and GABAergic Function in Individuals with Fragile-X Syndrome
NCT00780182Comparative Bioavailability and Effect of Food on CMX001 in Healthy Volunteers
NCT05772429Long-Term Follow-Up of a Cohort of Participants Prescribed Epidyolex in France in a Real-life Setting
NCT03954106A Safety and Efficacy Study of Defibrotide in the Prevention of Chimeric Antigen Receptor-T-cell-associated Neurotoxicity
NCT01843634Ph I Safety and Efficacy of ODSH in Patients Receiving Induction or Consolidation Therapy for Acute Myeloid Leukemia
NCT00674609A Study of Sativex® for Pain Relief in Patients With Advanced Malignancy
NCT02325011An Study to Evaluate the Effects of Fluconazole on the Pharmacokinetics (PK) of Sativex® in Healthy Subjects With Cannabis Experience.
NCT01643408A Study of Erwinaze Administered Intravenously in Patients Who Had an Allergy to Frontline Asparaginase Therapy
NCT04578444An Expanded Access Treatment Protocol of Zanidatamab (ZW25) in Patients With HER2-Positive Advanced Biliary Tract Cancer
NCT04485104Assessment of Adjunctive Cannabidiol Oral Solution (GWP42003-P) in Children With Tuberous Sclerosis Complex (TSC), Dravet Syndrome (DS), or Lennox-Gastaut Syndrome (LGS) Who Experience Inadequately-controlled Seizures
NCT02332655Cannabidiol Expanded Access Study in Medically Refractory Sturge-Weber Syndrome
NCT02525692Oral ONC201 in Adult Recurrent Glioblastoma
NCT02053272A Study of GWP42004 as Add on to Metformin in the Treatment of Participants With Type 2 Diabetes
NCT02150928An Open-Label, Single-Arm, Multicenter Pharmacokinetic Study of Intramuscular Erwinaze® (Asparaginase Erwinia Chrysanthemi)/Erwinase® (Crisantaspase)
NCT06261450Effect of CBD on the Brain
NCT05024552Vyxeos Plus Gilteritinib in Relapsed or Refractory, FLT3-Mutated AML
NCT00594945Study of Intranasal Clonazepam in Adult Subjects With Epileptic Seizures
NCT06043427Paclitaxel and Ramucirumab +/- Zanidatamab in HER2 Postive Advanced Gastroesophageal Adenocarcinoma
NCT03878927CPX-351+GO in Subjects 55 Years Old, or Older, With AML
NCT02544763A Randomized Controlled Trial of Cannabidiol (GWP42003-P, CBD) for Seizures in Tuberous Sclerosis Complex (GWPCARE6)
NCT02348632"A Long-Term Safety Study of JZP-110 in the Treatment of Excessive Sleepiness in Subjects With Narcolepsy or OSA"
NCT00628498Defibrotide for Patients With Hepatic Veno-occlusive Disease: A Treatment IND Study
NCT07156435Vyxeos® With Clofarabine for Pediatric AML
NCT01322464Study to Assess Food Effect on Sativex Bioavailability
NCT03339401The AdAPT Trial; Adenovirus After Allogeneic Pediatric Transplantation
NCT04899947Child and Adolescent Registry for Participants With Narcolepsy
NCT02439957A Phase 3 Study of Brincidofovir Versus Valganciclovir for the Prevention of Cytomegalovirus
NCT03335267Investigator Initiated Trial of CPX-351 for Untreated Acute Myeloid Leukemia
NCT04038437A Trial of CPX-351 Lower Intensity Therapy (LIT) Plus Venetoclax as First Line Treatment for Subjects With AML
NCT03295396ONC201 in Adults With Recurrent H3 K27M-mutant Glioma
NCT02224690A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P; CBD) as Adjunctive Treatment for Seizures Associated With Lennox-Gastaut Syndrome in Children and Adults
NCT02056782A Pilot Study of Dociparstat Sodium (ODSH) in Acute Myeloid Leukemia
NCT00822094Trial of CPX-351 in Adult Patients With First Relapse Acute Myeloid Leukemia (AML)
NCT00514995Sodium Oxybate in the Treatment of Binge Eating Disorder
NCT01217112GWMD1092 - GWP42003 : GWP42004 Together Plus Alone in Type II Diabetes
NCT04982354Induction Therapy for Patients With FLT3 Mutated Acute Myeloid Leukemia
NCT05720494A Multiple Ascending Dose Study to Investigate the Safety, Tolerability, and Pharmacokinetics of JZP441 in Healthy Participants
NCT02221869A Multicenter Study of the Efficacy and Safety of Xyrem With an Open- Label Pharmacokinetic Evaluation and Safety Extension in Pediatric Subjects With Narcolepsy With Cataplexy
NCT01606189A Study to Compare Sublingual Cannabis Based Medicine Extracts With Placebo to Treat Brachial Plexus Injury Pain
NCT04592159Study of the Safety and Efficacy of Nabiximols Oromucosal Spray Versus Placebo in Patients With Post-traumatic Stress Disorder
NCT05288283Efficacy and Safety of GWP42003-P Oral Solution in Children With Epilepsy With Myoclonic-atonic Seizures
NCT07290985AACR Adaptive Biomarker-Driven Organ Preservation Trial in Gastroesophageal Adenocarcinomas
NCT03575325Vyxeos(CPX-351) in Adults w R/R Acute Lymphoblastic Leukemia
NCT01361607Sativex® for Relieving Persistent Pain in Patients With Advanced Cancer
NCT00713817A Study to Determine the Maintenance of Effect After Long-term Treatment of Sativex® in Subjects With Neuropathic Pain
NCT07192068Clinical Trial Evaluating the Activity of Zanidatamab for the Treatment of Patients With Solid Tumors With an Alteration of the HER2 Gene.
NCT00272948Pediatric Trial Investigating the Incidence & Outcome of Veno-Occlusive Disease With the Prophylactic Use of Defibrotide
NCT00875693A Novel Sequential Treatment of Salvage and Reduced Intensity Conditioning (RIC) Chemotherapy for Allogeneic Stem-Cell Transplantation (SCT) for Primary Refractory and Relapsed Acute Myelogenous Leukemia (AML)